Proton therapy for post-operative radiation therapy of non-small cell lung cancer.

about

Proton therapy for post-operative radiation therapy of non-small cell lung cancer.

Item

http://www.wikidata.org/entity/Q55041495

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Proton therapy for post-operative radiation therapy of non-small cell lung cancer.

@en

Proton therapy for post-operative radiation therapy of non-small cell lung cancer.

@nl

type

Item

label

Proton therapy for post-operative radiation therapy of non-small cell lung cancer.

@en

Proton therapy for post-operative radiation therapy of non-small cell lung cancer.

@nl

prefLabel

Proton therapy for post-operative radiation therapy of non-small cell lung cancer.

@en

Proton therapy for post-operative radiation therapy of non-small cell lung cancer.

@nl

P1476

Proton therapy for post-operative radiation therapy of non-small cell lung cancer.

@en

P2093

Annemarie Fernandes Shepherd

http://www.w3.org/2001/XMLSchema#string

P2860

Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base.

Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two facto

Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: a meta-analysis.

Trends in the use of postoperative radiotherapy for resected non-small-cell lung cancer.

Cancer Statistics, 2017.

Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database.

An in-silico comparison of proton beam and IMRT for postoperative radiotherapy in completely resected stage IIIA non-small cell lung cancer.

Risk of ischemic heart disease in women after radiotherapy for breast cancer.

The risk of death from heart disease in patients with nonsmall cell lung cancer who receive postoperative radiotherapy: analysis of the Surveillance, Epidemiology, and End Results database.

P304

205-209

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/TLCR.2018.03.25

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29876320

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

5960662

http://www.w3.org/2001/XMLSchema#string